- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01186276
Dietary Maneuvers to Reduce Production of Colon-Derived Uremic Solutes
August 22, 2022 updated by: Stanford University
This study will assess whether dietary fiber supplements can reduce the production of chemicals which are produced by colon bacteria and normally excreted from the body by the kidney, but build up in the body in patients on hemodialysis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The study procedures will consist of:
- taking a dietary supplement containing either fiber or starch (starch serves as a control for fiber) for six weeks. The fiber dose initially employed will be 30 g/day of high amylose corn and the control starch dose employed will be 30 g/day of waxy corn starch. Supplements which come in dry powder form will be mixed in liquid or food for consumption.
- filling out a food record and a quality of life questionnaire
- keeping a diary of any gi symptoms
- collecting samples of blood, spent dialysate, urine(if the patient still makes urine) and stool.
Study Type
Interventional
Enrollment (Actual)
58
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Palo Alto, California, United States, 94304
- VA Palo Alto Health Care System
-
Redwood City, California, United States, 94063
- Satellite Dialysis
-
San Jose, California, United States, 95128
- SCVMC
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- stable dialysis patients able to provide consent.
Exclusion Criteria:-- known g.i. disease
- use of antibiotics for the last two month or expected antibiotic use
- recent hospitalization or other event resulting in instability of food intake
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
PLACEBO_COMPARATOR: Corn Starch
Corn starch will serve as the control arm.
|
Corn starch to be consumed daily for 6 weeks.
This will serve as the control/placebo arm.
|
|
EXPERIMENTAL: Fiber
Fiber will serve as the intervention.
|
Dietary fiber supplements to be consumed daily for 6 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Plasma level of p-cresol sulfate
Time Frame: 8 weeks
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Caloric intake
Time Frame: 8 weeks
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Timothy W Meyer, Stanford University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
July 1, 2010
Primary Completion (ACTUAL)
September 1, 2015
Study Completion (ACTUAL)
September 1, 2015
Study Registration Dates
First Submitted
August 19, 2010
First Submitted That Met QC Criteria
August 20, 2010
First Posted (ESTIMATE)
August 23, 2010
Study Record Updates
Last Update Posted (ACTUAL)
August 25, 2022
Last Update Submitted That Met QC Criteria
August 22, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SU-07292010-6626
- NIH R21AT005123-01A1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Kidney Failure, Chronic
-
Centre Hospitalier Universitaire DijonTerminatedEnd-stage Chronic Kidney FailureFrance
-
Angiodynamics, Inc.TerminatedChronic Kidney Disease | Acute Kidney Injury | Acute Renal Failure | Renal Failure Chronic Contrast InducedUnited States
-
Texas A&M UniversityWithdrawnChronic Kidney FailureUnited States
-
Hopital Jean MinjozUnknownCardiac Surgical Procedures | Preoperative KIDNEY FAILURE, CHRONIC | Postoperative KIDNEY FAILURE, ACUTEFrance
-
Pharmagest InteractiveCompletedChronic Kidney DiseasesFrance
-
Ozge AKBABAAtaturk UniversityCompletedChronic Kidney FailureTurkey
-
Chinese PLA General HospitalCompletedKidney Failure,ChronicChina
-
Fatma Alzahraa Mohamed Ibrahim Hassan HaggagUnknown
-
Federal University of Health Science of Porto AlegreCompleted
-
Bristol-Myers SquibbCompletedKidney Transplantation | Chronic Kidney FailureUnited States, Argentina, Australia, Germany, Italy, South Africa, Spain, Brazil, Mexico, Belgium, France, Hungary, Switzerland, India, Canada, Austria, Czech Republic, Poland, Israel, Sweden, Turkey
Clinical Trials on Corn starch
-
University of ManitobaCompletedChronic Kidney DiseasesCanada
-
Purdue UniversityCompletedObesity | Diabetes Mellitus, Type 2 | Appetitive BehaviorUnited States
-
Sarawak General HospitalCRAUN Research Sdn. Bhd.CompletedDiabetes Mellitus, Type 2Malaysia
-
University of MinnesotaTate and Lyle Ingredients FranceCompleted
-
University of MinnesotaGeneral Mills; Tate and Lyle Ingredients FranceCompleted
-
Universidad Autonoma de Baja CaliforniaActive, not recruitingOverweight and ObesityMexico
-
Sergio Marques BorghiUniversidade Norte do ParanáRecruiting
-
Clasado LimitedUniversity of ReadingCompleted
-
Guizhou Provincial People's HospitalCompleted
-
Clasado LimitedGeneral Hospital, States of JerseyCompletedHealthyUnited Kingdom